At the start of 2023, we released a series of three articles which sought to provide guidance on driving collaborative discussions between manufacturers and US Payers. This came against the backdrop of innovative and often costly therapies coming to market (many via expedited pathways), as well as an evolving legislative landscape in this area, making it more important than ever to participate in dialogue earlier and with the right information.
In this guide, Lumanity’s expert authors, Jeff Lee, Vice President of US Value Strategy and Services, and Lisa Cashman, Vice President of Strategic Payer Content, re-publish their original articles with additional insights and top tips on sharing Health Care Economic Information (HCEI) and engaging in effective Pre-Approval Information Exchange (PIE) following recent legislative changes to support these discussions.
Fill out the form on the right to download the guide.
Download the pdf
"*" indicates required fields
